Literature DB >> 7760615

Transmission of HIV in dialysis centre.

M Velandia1, S K Fridkin, V Cárdenas, J Boshell, G Ramirez, L Bland, A Iglesias, W Jarvis.   

Abstract

In August, 1993, 13 dialysis patients at one dialysis centre in Colombia, South America, were found to be HIV positive, and this prompted an epidemiological investigation. We carried out a cohort study of all dialysis centre patients during January, 1992 to December, 1993 (epidemic period) to determine risk factors for HIV seroconversion. Haemodialysis and medical records were reviewed, dialysis centre staff and surviving patients were interviewed, and dialysis practices were observed. Stored sera from all dialysis centre patients were tested for HIV antibody. 12 (52%) of 23 patients tested positive for HIV antibody by enzyme immunoassay and western blot during the epidemic period. Of the 23 tested, 9 (39%) converted from HIV antibody negative to positive (seroconverters) and 10 (44%) remained HIV negative (seronegatives). The HIV seroconversion rate was higher among patients dialysed at the centre while a new patient, who was HIV seropositive, was dialysed there (90% vs 0%; p < 0.01), or when the dialysis centre reprocessed access needles, dialysers, and bloodlines (60% vs 0%). While 2 of 9 HIV seroconverters had had sex with prostitutes, none had received unscreened blood products or had other HIV risk factors. No surgical or dental procedures were associated with HIV seroconversion. Dialysers were reprocessed separately with 5% formaldehyde and were labelled for use on the same patient. Access needles were reprocessed by soaking them in a common container with a low-level disinfectant, benzalkonium chloride; 4 pairs of needles were placed in one pan creating the potential for cross-contamination or use of one patient's needles on another patient. HIV transmission at the dialysis centre was confirmed. Improperly reprocessed patient-care equipment, most probably access needles, is the likely mechanism of transmission. This outbreak was discovered by accident and similar transmission may be occurring in many other countries where low-level disinfectants are used to sterilise critical patient-care equipment.

Entities:  

Mesh:

Year:  1995        PMID: 7760615     DOI: 10.1016/s0140-6736(95)92603-8

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  8 in total

1.  Nosocomial transmission of hepatitis C virus.

Authors:  R Schvarcz; B Johansson; B Nyström; A Sönnerborg
Journal:  Infection       Date:  1997 Mar-Apr       Impact factor: 3.553

2.  Infections in hemodialysis: a concise review. Part II: blood transmitted viral infections.

Authors:  T Eleftheriadis; V Liakopoulos; K Leivaditis; G Antoniadi; I Stefanidis
Journal:  Hippokratia       Date:  2011-04       Impact factor: 0.471

3.  Genetic and serological evidence for multiple instances of unrecognized transmission of hepatitis C virus in hemodialysis units.

Authors:  M Mizuno; T Higuchi; K Kanmatsuse; M Esumi
Journal:  J Clin Microbiol       Date:  1998-10       Impact factor: 5.948

4.  Blood-borne viral infections in pediatric hemodialysis.

Authors:  Shina Menon; Raj Munshi
Journal:  Pediatr Nephrol       Date:  2018-07-21       Impact factor: 3.714

5.  HIV transmission at a Saudi Arabia hemodialysis unit.

Authors:  Faisal Mashragi; Robert S Bernstein; Mohammad Al-Mazroa; Jaffar A Al-Tawfiq; Sanaa Filemban; Abdullah Assiri; Elaine Furukawa; Mohammad Al Hazmi; Abdullah Alzahrani; Gwen Stephens; Ziad A Memish
Journal:  Clin Infect Dis       Date:  2014-05-20       Impact factor: 9.079

6.  Conflicting Views in Narratives on HIV Transmission via Medical Care.

Authors:  Michael A Vance
Journal:  J Int Assoc Provid AIDS Care       Date:  2019 Jan-Dec

Review 7.  Update on current management of chronic kidney disease in patients with HIV infection.

Authors:  Nina E Diana; Saraladevi Naicker
Journal:  Int J Nephrol Renovasc Dis       Date:  2016-09-16

8.  Clinical practice guideline management of blood borne viruses within the haemodialysis unit.

Authors:  Elizabeth Garthwaite; Veena Reddy; Sam Douthwaite; Simon Lines; Kay Tyerman; James Eccles
Journal:  BMC Nephrol       Date:  2019-10-28       Impact factor: 2.388

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.